Azmi Nabulsi - 19 Dec 2024 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
Chief Operating Officer
Signature
/s/ Molly Henderson, Attorney-in-Fact for Azmi Nabulsi
Issuer symbol
PHAT
Transactions as of
19 Dec 2024
Transactions value $
-$8,944
Form type
4
Filing time
20 Dec 2024, 16:21:13 UTC
Previous filing
17 Jul 2024
Next filing
23 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Sale -$8.94K -1.12K -0.47% $8.00 239K 19 Dec 2024 Direct F1
holding PHAT Common Stock 3.58K 19 Dec 2024 By 401(k)
holding PHAT Common Stock 786K 19 Dec 2024 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.